Analysts: Keryx Biopharmaceuticals Inc (KERX.OQ)
KERX.OQ on NASDAQ Stock Exchange Capital Market
9.05USD
4:00pm EDT
9.05USD
4:00pm EDT
Price Change (% chg)
$-0.05 (-0.55%)
$-0.05 (-0.55%)
Prev Close
$9.10
$9.10
Open
$9.20
$9.20
Day's High
$9.28
$9.28
Day's Low
$8.79
$8.79
Volume
535,338
535,338
Avg. Vol
553,951
553,951
52-wk High
$9.98
$9.98
52-wk Low
$1.68
$1.68
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.08 | December | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 4 | 4 | 4 | 4 |
| (2) OUTPERFORM | 6 | 6 | 5 | 4 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.60 | 1.60 | 1.56 | 1.50 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 9 | 2.22 | 20.00 | 0.00 | 0.00 |
| Quarter Ending Dec-13 | 9 | 0.00 | 0.00 | 0.00 | 2.77 |
| Year Ending Dec-13 | 9 | 9.22 | 27.00 | 7.00 | 9.48 |
| Year Ending Dec-14 | 8 | 49.89 | 92.35 | 4.10 | 46.19 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 9 | -0.08 | 0.15 | -0.13 | -0.08 |
| Quarter Ending Dec-13 | 9 | -0.11 | -0.10 | -0.14 | -0.06 |
| Year Ending Dec-13 | 9 | -0.33 | -0.07 | -0.40 | -0.26 |
| Year Ending Dec-14 | 8 | 0.00 | 0.84 | -0.40 | 0.19 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Mar-13 | 5.83 | 7.00 | 1.17 | 20.00 |
| Quarter Ending Dec-12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jun-12 | 0.30 | 0.00 | 0.30 | 100.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 2.22 | 2.22 | 2.22 | 2.50 | 0.00 |
| Quarter Ending Dec-13 | 0.00 | 0.00 | 0.00 | 0.00 | 2.77 |
| Year Ending Dec-13 | 9.22 | 9.22 | 9.22 | 9.50 | 9.48 |
| Year Ending Dec-14 | 49.89 | 48.79 | 48.79 | 51.84 | 46.19 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates